16.87

1.00% -0.17

Nurix Therapeutics Inc (NRIX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$17.04

Offen:

$17.25

24-Stunden-Volumen:

500.15K

Relative Volume:

0.64

Marktkapitalisierung:

$1.28B

Einnahmen:

$54.55M

Nettoeinkommen (Verlust:

$-193.57M

KGV:

-5.8374

EPS:

-2.89

Netto-Cashflow:

$-181.86M

1W Leistung:

-4.09%

1M Leistung:

-13.93%

6M Leistung:

-29.44%

1J Leistung:

+68.03%

1-Tages-Spanne:

$16.75

$17.46

1-Wochen-Bereich:

$16.56

$18.07

52-Wochen-Spanne:

$9.9105

$29.56

Nurix Therapeutics Inc Stock (NRIX) Company Profile

Firmenname

Nurix Therapeutics Inc

Sektor

Healthcare (1169)

Branche

Biotechnology (678)

Telefon

(415) 660-5320

Adresse

1700 OWENS STREET, SUITE 205, SAN FRANCISCO

Mitarbeiter

286

Twitter

Nächster Verdiensttermin

2024-10-14

Neueste SEC-Einreichungen

NRIX's Discussions on Twitter

Vergleichen Sie NRIX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NRIX Nurix Therapeutics Inc	16.87	1.28B	54.55M	-193.57M	-181.86M	-2.89
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-10	Eingeleitet	BTIG Research	Buy
2024-12-06	Eingeleitet	BMO Capital Markets	Outperform
2024-10-24	Eingeleitet	UBS	Buy
2024-10-11	Eingeleitet	Jefferies	Buy
2024-09-06	Fortgesetzt	Robert W. Baird	Outperform
2024-07-31	Eingeleitet	Truist	Buy
2023-06-26	Fortgesetzt	Oppenheimer	Outperform
2023-03-09	Eingeleitet	Barclays	Overweight
2023-02-28	Eingeleitet	Oppenheimer	Outperform
2022-10-11	Eingeleitet	Morgan Stanley	Equal-Weight
2022-05-31	Hochstufung	Wells Fargo	Equal Weight → Overweight
2022-02-10	Eingeleitet	Wells Fargo	Equal Weight
2021-12-29	Eingeleitet	H.C. Wainwright	Buy
2021-10-14	Eingeleitet	SVB Leerink	Outperform
2021-06-04	Fortgesetzt	Robert W. Baird	Outperform
2021-04-30	Fortgesetzt	Piper Sandler	Overweight
2021-04-30	Eingeleitet	RBC Capital Mkts	Outperform
2021-04-14	Eingeleitet	Berenberg	Buy
2020-11-19	Eingeleitet	Robert W. Baird	Outperform
2020-08-18	Eingeleitet	JP Morgan	Overweight
2020-08-18	Eingeleitet	Needham	Buy
2020-08-18	Eingeleitet	Piper Sandler	Overweight
2020-08-18	Eingeleitet	Stifel	Buy

Alle ansehen

Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten

07:35 AM

Analysts Predict How High Nurix Therapeutics Inc (NRIX) Will Go. - Stocks Register

07:35 AM

Feb 19, 2025

Kymera Therapeutics: Plenty Of Potential, But A Long Way From The Finish Line (KYMR) - Seeking Alpha

Feb 19, 2025

Feb 18, 2025

Nurix Therapeutics: A Story To Monitor (NASDAQ:NRIX) - Seeking Alpha

Feb 18, 2025

Feb 17, 2025

Sumitomo Mitsui Trust Group Inc. Has $14.87 Million Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Feb 17, 2025

Feb 16, 2025

Nurix Therapeutics (NRIX) Projected to Post Earnings on Thursday - MarketBeat

Feb 16, 2025

Feb 14, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 14, 2025

Strategic Equity Package: Nurix Therapeutics Secures Top Talent with $8.2M Employee Stock Awards - StockTitan

Feb 14, 2025

Feb 13, 2025

Sumitomo Mitsui Trust Group Inc. Raises Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World

Feb 13, 2025

Nurix Therapeutics (NRIX) Projected to Post Quarterly Earnings on Thursday - Defense World

Feb 13, 2025

Feb 12, 2025